+Compare
SGRY
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
4.08B

SGRY Surgery Partners Forecast, Technical & Fundamental Analysis

a company which engages in health care services

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for SGRY with price predictions
07:00 PM EST Nov 30, 2023

SGRY in upward trend: price rose above 50-day moving average on November 14, 2023

SGRY moved above its 50-day moving average on November 14, 2023 date and that indicates a change from a downward trend to an upward trend. In of 26 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 07, 2023. You may want to consider a long position or call options on SGRY as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SGRY just turned positive on October 31, 2023. Looking at past instances where SGRY's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for SGRY crossed bullishly above the 50-day moving average on November 16, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SGRY advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 293 cases where SGRY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGRY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SGRY broke above its upper Bollinger Band on November 14, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SGRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.021) is normal, around the industry mean (4.306). P/E Ratio (0.000) is within average values for comparable stocks, (72.109). SGRY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.357). SGRY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.023). P/S Ratio (1.412) is also within normal values, averaging (18.397).

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 3.43B. The market cap for tickers in the group ranges from 1.86K to 67.28B. HCA holds the highest valuation in this group at 67.28B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 1%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was -5%. CCEL experienced the highest price growth at 36%, while NVOS experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 326%. For the same stocks of the Industry, the average monthly volume growth was 51% and the average quarterly volume growth was 56%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 61
Price Growth Rating: 61
SMR Rating: 81
Profit Risk Rating: 84
Seasonality Score: 27 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

SGRY is expected to report earnings to rise 98.11% to 37 cents per share on February 27

Surgery Partners SGRY Stock Earnings Reports
Q4'23
Est.
$0.38
Q3'23
Beat
by $0.05
Q2'23
Beat
by $0.20
Q1'23
Beat
by $0.07
Q4'22
Beat
by $0.07
The last earnings report on November 07 showed earnings per share of 18 cents, beating the estimate of 14 cents. With 566.46K shares outstanding, the current market capitalization sits at 4.08B.
A.I. Advisor
published General Information

General Information

a company which engages in health care services

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Hospital Or Nursing Management
Address
340 Seven Springs Way
Phone
+1 615 234-5900
Employees
12200
Web
https://www.surgerypartners.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MDYG72.301.53
+2.16%
SPDR® S&P 400 Mid Cap Growth ETF
IWFH15.440.20
+1.34%
iShares Virtual Work and Life Mltsct ETF
CRAK35.120.24
+0.69%
VanEck Oil Refiners ETF
NXTG73.450.37
+0.51%
First Trust IndXX NextG ETF
GJAN33.930.12
+0.34%
FT Cboe Vest U.S. Eq Mod Buffr ETF - Jan

SGRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGRY has been closely correlated with THC. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SGRY jumps, then THC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGRY
1D Price
Change %
SGRY100%
+3.97%
THC - SGRY
70%
Closely correlated
+2.90%
HCA - SGRY
60%
Loosely correlated
+0.75%
SEM - SGRY
59%
Loosely correlated
+3.76%
UHS - SGRY
50%
Loosely correlated
+0.16%
ENSG - SGRY
46%
Loosely correlated
+1.32%
More

Groups containing SGRY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGRY
1D Price
Change %
SGRY100%
+3.97%
SGRY
(undefined stocks)
89%
Closely correlated
+3.43%
nursing service
(undefined stocks)
72%
Closely correlated
+2.70%
Medical/Nursing Services
(undefined stocks)
70%
Closely correlated
+1.44%
hospital
(undefined stocks)
63%
Loosely correlated
+2.28%
healthcare
(undefined stocks)
53%
Loosely correlated
+2.00%
More